I have a particular focus on disease prevention strategies and treating patients with high-risk disease and relapsed disease. I also treat pre-myeloma conditions, including smoldering multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS), and related disorders such as Waldenstrom macroglobulinemia, a rare blood cancer caused by excess of abnormal white blood cells in the bone marrow.

I use the latest technology and my specialized knowledge of genetics to “fingerprint” and distinguish the different types of multiple myeloma. This helps create tailored therapeutic approaches to various subtypes of melanoma. Customizing therapy in this way can more precisely target the cancerous cells and achieve the best outcomes with minimum side effects.